National Healthcare

US · NHC #2365 by market cap Listed 1970

221.19 -7.08 -3.10%

Live - 5344 symbols - heartbeat 222s ago · 2026-10-08 07:58

Pre-market 221.19 0.00%

After-hours 221.19 0.00%

Overnight 218.62 -1.16%

Market cap: 3.46B
P/E (TTM): 24.85
P/B: 3.09
EPS: 7.67
Div yield: 1.17%
52W pos: 86%

Reader sentiment Are you bullish or bearish on NHC?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Mixed / stable

The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
Total institutional ownership (as a % of shares) was little changed.

Institutional ownership

Held by institutions: 73.23% +0.03pp
Institutions: 296 +1
As of: 2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund60.86%

Individual/Insider12.21%

Corporate Pension Plan6.60%

Hedge Fund2.94%

Government Pension Fund1.05%

Public Company1.01%

Private Company0.55%

Insurance Company0.14%

Other14.59%

Top holders as of 2026-06-30

BlackRock 12.62% · 1.98M sh

National Healthcare Corp., ESOP 6.58% · 1.03M sh

Morgan Stanley Institutional Investment Advisors LLC 6.57% · 1.03M sh

Dimensional Fund Advisors 5.94% · 929.69K sh

Vanguard Portfolio Management, LLC 5.17% · 809.22K sh

First Trust Advisors L.P. 4.66% · 730.57K sh

W. Adams 4.50% · 705.01K sh

Vanguard Capital Management, LLC 4.07% · 637.11K sh

State Street Global Advisors 3.36% · 526.73K sh

Robert Adams 2.83% · 443.92K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 27 buys · 23 sells

Name	Role	Stake
W. Adams	Independent Director	4.50%
Robert Adams	Independent Chairperson	2.83%
Richard LaRoche	Independent Director	2.30%
R. Ussery	President	1.01%
Emil Hassan	Independent Director	0.42%
Stephen Flatt	Chief Executive Officer	0.42%
James Abernathy	Independent Director	0.28%
Brian Kidd	Senior Vice President	0.15%
B. Flatt	Chief Information Officer	0.10%
Vicki Dodson	Senior Vice President of Patient Services	0.07%

Insider transactions most recent Form 4 filings

Date	Name	Role	Type	Shares	Price
2026-09-21	Vicki Dodson	Senior Vice President of Patient Services	Open Market Disposition	-4,834	$225.00
2026-09-10	Brian Kidd	Senior Vice President	Open Market Disposition	-6,813	$225.70
2026-09-09	Josh McCreary	Senior Vice President	Open Market Disposition	-2,719	$222.73–225.59
2026-08-27	B. Flatt	Chief Information Officer	Open Market Disposition	-7,000	$221.21–237.18
2026-08-24	David Gifford	Independent Director	Open Market Disposition	-1,779	$225.42
2026-08-19	David Gifford	Independent Director	Derivative Exercise and Sale	-4,691	$171.42–236.75
2026-08-19	David Gifford	Independent Director	Derivative Exercise and Retained	+1,788	$171.42
2026-08-18	Stephen Flatt	Chief Executive Officer	Open Market Disposition	-1,500	$237.08
2026-08-12	David Gifford	Independent Director	Derivative Exercise and Retained	+1,021	$171.42
2026-06-21	Emil Hassan	Independent Director	Open Market Disposition	-5,937	$200.00
2026-06-15	Emil Hassan	Independent Director	Open Market Disposition	-1,563	$199.98
2026-06-15	Brian Kidd	Senior Vice President	Other Disposition	-500	--
2026-06-07	Robert Adams	Independent Chairperson	Derivative Exercise and Sale	-4,000	--
2026-05-31	Lisa Piercey	Director	Open Market Acquisition	+949	$184.26
2026-05-21	B. Flatt	Chief Information Officer	Derivative Exercise and Sale	-2,739	$94.10–196.00
2026-05-21	B. Flatt	Chief Information Officer	Derivative Exercise and Retained	+1,261	$94.10
2026-05-20	Richard LaRoche	Independent Director	Open Market Disposition	-7,500	$195.14
2026-05-19	Stephen Flatt	Chief Executive Officer	Other Disposition	-26	--
2026-05-18	Timothy Shelly	Officer	Open Market Disposition	-1,853	$197.22
2026-05-13	Stephen Flatt	Chief Executive Officer	Derivative Exercise and Sale	-4,492	$90.62–197.96

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 07:58:33 · For reference only, not investment advice and not tailored to your situation.